Beijing Luzhu Biotechnology Toekomstige groei
Future criteriumcontroles 2/6
Beijing Luzhu Biotechnology is forecast to grow earnings and revenue by 47.5% and 59.7% per annum respectively. EPS is expected to grow by 19.3% per annum. Return on equity is forecast to be -403% in 3 years.
Belangrijke informatie
47.5%
Groei van de winst
19.3%
Groei van de winst per aandeel
| Biotechs winstgroei | 41.8% |
| Inkomstengroei | 59.7% |
| Toekomstig rendement op eigen vermogen | -403.0% |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 24 Sep 2024 |
Recente toekomstige groei-updates
Recent updates
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 528 | -126 | -156 | -106 | 3 |
| 12/31/2025 | 67 | -349 | -331 | -268 | 3 |
| 12/31/2024 | 1 | -278 | -276 | -205 | 3 |
| 6/30/2024 | N/A | -280 | -235 | -167 | N/A |
| 3/31/2024 | N/A | -265 | -255 | -179 | N/A |
| 12/31/2023 | N/A | -249 | -276 | -190 | N/A |
| 9/30/2023 | N/A | -201 | -307 | -153 | N/A |
| 6/30/2023 | N/A | -152 | -339 | -117 | N/A |
| 3/31/2023 | N/A | -439 | -314 | -97 | N/A |
| 12/31/2022 | N/A | -725 | -289 | -77 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: 2480 is forecast to remain unprofitable over the next 3 years.
Winst versus markt: 2480 is forecast to remain unprofitable over the next 3 years.
Hoge groeiwinsten: 2480 is forecast to remain unprofitable over the next 3 years.
Omzet versus markt: 2480's revenue (59.7% per year) is forecast to grow faster than the Hong Kong market (7.7% per year).
Hoge groei-inkomsten: 2480's revenue (59.7% per year) is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: 2480 is forecast to be unprofitable in 3 years.